Eugeni Ryadnov

Eugeni Ryadnov

Auto-generated profile, based on publicly available information

Eugeni Ryadnov

UCL Queen Square Motor Neuron Disease Centre and Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MKMatthew J. Keuss
Matthew J. Keuss
PHPeter Harley
Peter Harley
EREugeni Ryadnov
Eugeni Ryadnov
RJRachel E. Jackson
Rachel E. Jackson
MZMatteo Zanovello
Matteo Zanovello
PFPietro Fratta
Pietro Fratta
TDP-43 loss of function induces multiple splicing changes, including a cryptic exon in the amyotrophic lateral sclerosis and fronto-temporal lobar degeneration risk gene UNC13A, leading to nonsense-mediated decay of UNC13A transcripts and loss of protein. UNC13A is an active zone protein with an integral role in coordinating pre-synaptic function. Here, we show TDP-43 depletion induces a severe reduction in synaptic transmission, leading to an asynchronous pattern of network activity. We demonstrate that these deficits are largely driven by a single cryptic exon in UNC13A. Antisense oligonucleotides targeting the UNC13A cryptic exon robustly rescue UNC13A protein levels and restore normal synaptic function, providing a potential new therapeutic approach for ALS and other TDP-43-related disorders.

23 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SBSam Bryce-Smith
Sam Bryce-Smith
ABAnna-Leigh Brown
Anna-Leigh Brown
PMPuja R. Mehta
Puja R. Mehta
FMFrancesca Mattedi
Francesca Mattedi
AMAlla Mikheenko
Alla Mikheenko
PFPietro Fratta
Pietro Fratta
Nuclear depletion and cytoplasmic aggregation of the RNA-binding protein TDP-43 is the hallmark of ALS, occurring in over 97% of cases. A key consequence of TDP-43 nuclear loss is the de-repression of cryptic exons. Whilst TDP-43 regulated cryptic splicing is increasingly well catalogued, cryptic alternative polyadenylation (APA) events, which define the 3’ end of last exons, have been largely overlooked, especially when not associated with novel upstream splice junctions. We developed a novel bioinformatic approach to reliably identify distinct APA event types: alternative last exons (ALE), 3’UTR extensions (3’Ext) and intronic polyadenylation (IPA) events. We identified novel neuronal cryptic APA sites induced by TDP-43 loss of function by systematically applying our pipeline to a compendium of publicly available and in house datasets. We find that TDP-43 binding sites and target motifs are enriched at these cryptic events and that TDP-43 can have both repressive and enhancing action on APA. Importantly, all categories of cryptic APA can also be identified in ALS and FTD post mortem brain regions with TDP-43 proteinopathy underlining their potential disease relevance. RNA-seq and Ribo-seq analyses indicate that distinct cryptic APA categories have different downstream effects on transcript and translation. Intriguingly, cryptic 3’Exts occur in multiple transcription factors, such as ELK1 , SIX3, and TLX1, and lead to an increase in wild-type protein levels and function. Finally, we show that an increase in RNA stability leading to a higher cytoplasmic localisation underlies these observations. In summary, we demonstrate that TDP-43 nuclear depletion induces a novel category of cryptic RNA processing events and we expand the palette of TDP-43 loss consequences by showing this can also lead to an increase in normal protein translation.

6 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
JVJose Norberto Sagullo Vargas
Jose Norberto Sagullo Vargas
ABAnna-Leigh Brown
Anna-Leigh Brown
KSKai Sun
Kai Sun
CHCathleen Hagemann
Cathleen Hagemann
BGBethany Geary
Bethany Geary
LMLaura Meysman
Laura Meysman
The cell-intrinsic capacity of neurons to regenerate axons requires widespread coordination of the transcriptome, activation of multiple kinases, and reorganization of the cytoskeleton. Axonal repair is also influenced by extrinsic activating factors, such as neurotrophins. Here, we reveal that brain-derived neurotrophic factor (BDNF) amplifies multiple neuron-intrinsic programs to foster axonal regeneration in human motor neurons. Through metabolic RNA sequencing and phosphoproteomic profiling, we elucidate BDNF signalling and its role in axonal regeneration. We discover that BDNF controls RNA stability and transcriptional programs that converge with regeneration-associated gene (RAG) sets. We further unveil that BDNF governs the phosphorylation of multiple proteins essential for cytoskeletal dynamics, a major determinant of effective nerve regeneration. Using compartmentalized neuronal cultures, we demonstrate that the regeneration driven by BDNF depends on the axon-specific activation of ERK/RSK/S6K kinase pathway. We propose a model in which BDNF augments neuron-intrinsic pathways to drive axonal regeneration in human motor neurons. Teaser: BDNF aids nerve repair by fine-tuning the metabolism of RNA and by changing the building blocks of the nerve cell cytoskeleton.

5 January 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
ESEmiliana De Santis
Emiliana De Santis
NFNilofar Faruqui
Nilofar Faruqui
CRCraig T. Russell
Craig T. Russell
JNJames E. Noble
James E. Noble
IKIbolya Kepiro
Ibolya Kepiro
MRMaxim Ryadnov
Maxim Ryadnov

30 November 2025 in bioRxiv
Verified
Preprint
Open access
PMPuja R. Mehta
Puja R. Mehta
TSTomas Solomon
Tomas Solomon
SPSarah Pickles
Sarah Pickles
PHPeter Harley
Peter Harley
MBMichela Barioglio
Michela Barioglio
MRMarc-David Ruepp
Marc-David Ruepp
TDP-43 nuclear depletion in amyotrophic lateral sclerosis (ALS) causes de-repression of cryptic exons (CEs) in multiple transcripts, including UNC13A and STMN2 , disrupting synaptic transmission and neurite outgrowth. We developed a therapeutic U7 snRNA (tU7) approach that suppresses TDP-43-dependent mis-splicing, restores target gene expression, rescues neuronal functions in human iPSC-derived neurons, and shows target engagement in vivo , positioning tU7-mediated splicing correction as a promising therapeutic strategy for ALS.

11 November 2026 in Nature
Verified
Journal Article
Open access
PDF file
MKMatthew J. Keuss
Matthew J. Keuss
PHPeter Harley
Peter Harley
EREugeni Ryadnov
Eugeni Ryadnov
RJRachel E. Jackson
Rachel E. Jackson
MBMoritz Boll
Moritz Boll
PFPietro Fratta
Pietro Fratta
TDP-43 nuclear depletion is a defining pathological feature of amyotrophic lateral sclerosis and frontotemporal dementia that induces widespread cryptic splicing defects in hundreds of transcripts 1–8 . Despite this, whether TDP-43 loss affects synaptic function has remained unclear. Here we show that TDP-43 loss induces a predegenerative state in which neurons remain structurally intact but suffer a substantial breakdown in synaptic communication. Genetic correction of a single cryptic splicing event in UNC13A was sufficient to rescue these deficits. We developed splice-switching antisense oligonucleotides that correct UNC13A cryptic splicing in human cortical and spinal motor neurons and in a humanized mouse model. In human neurons this intervention restored spontaneous and evoked synaptic vesicle release, release probability at individual synapses and wider network synchrony. Together, this establishes UNC13A splice correction as a mechanistically defined and genetically validated therapeutic strategy relevant to roughly 97% of patients with amyotrophic lateral sclerosis and roughly 50% of patients with frontotemporal dementia with TDP-43 pathology.